Allied Market Research

2024

Lyme Disease Diagnostics Market

Lyme Disease Diagnostics Market Size, Share, Competitive Landscape and Trend Analysis Report by Emerging Diagnostic Technology (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic acid Test) and by End User (Hospitals, Public/Private Laboratories, Physicians Office): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Lyme disease is a bacterial infection caused by species borrelia. It generally spreads in the humans through infected ticks bite. Patients infected with Lyme disease suffer from symptoms such as depression, fever, fatigue, and skin rashes. If the disease is diagnosed at an early stage then it can be treated with antibiotics. However, if the disease is left untreated then it affects, joint, heart, and central nervous system, and might become a cause for death.

Rise in prevalence of Lyme disease, increase in focus of government toward improvement of healthcare facilities, and emergence of new Lyme disease diagnostic tests drive the market. However, lack of awareness regarding the disease and inefficiency in Lyme disease testing majorly restricts the market. In addition, growth in interests of key players toward R&D of Lyme disease diagnosis is expected to provide lucrative growth opportunities for the market.

The report segments the global Lyme disease diagnostics market based on emerging diagnostic technology and end user. By diagnostic technology, the market is classified into serological test (ELISA and Western Blot), urine antigen tests, lymphocytic transformation test, immunofluorescent staining, nucleic acid test, and others. Based on end user, the market is categorized into hospitals, public/private laboratories, and physicians office. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players of the global Lyme disease diagnostics market include Abbott Laboratories, T2 Biosystems, Canon Life Sciences, Bio-Rad Laboratories, Alere Inc., Roche Diagnostics International Ltd., Graphene Frontiers, Covance Inc., Immunetics Inc., GlaxoSmithKline Pharmaceuticals Ltd., Boulder Diagnostics, Affymetrix Inc., Siemens AG, Baxter International Inc., and Fresenius Medical Care AG & Co.

Key Benefits

  • The study provides an in-depth analysis of the global Lyme disease diagnostics market and the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product assists to understand the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

Lyme Disease Diagnostics Market Report Highlights

Aspects Details
Lyme Disease Diagnostics Market By Emerging Diagnostic Technology
By Emerging Diagnostic Technology
  • Serological Test
    • ELISA
    • Western Blot
  • Urine Antigen Tests
  • Lymphocytic Transformation Test
  • Immunofluorescent Staining
  • Nucleic acid Test
Lyme Disease Diagnostics Market By End User
By End User
  • Hospitals
  • Public/Private Laboratories
  • Physicians Office
Lyme Disease Diagnostics Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Alere Inc., T2 Biosystems, Roche Diagnostics International Ltd., Abbott Laboratories, GlaxoSmithKline, Covance Inc., Graphene Frontiers, Immunetics Inc., Canon Life Sciences, Bio Rad Laboratories

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Lyme Disease Diagnostics Market

Global Opportunity Analysis and Industry Forecast, 2023-2032